These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8932802)

  • 1. Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.
    Locatelli F; Zecca M; Niemeyer C; Angelucci E; Arcese G; Bender-Gotze C; Bonetti F; Burdach S; Dini G; Ebell W; Friedrich W; Hasle H; Hermann J; Jacobsen N; Klingebiel T; Kremens B; Mann G; Miniero R; Pession A; Peters C; Paolucci P; Rossetti F; Schmid HJ; Stary J; Zimmermann M
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():63-8. PubMed ID: 8932802
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
    Cantù Rajnoldi A; Fenu S; Kerndrup G; van Wering ER; Niemeyer CM; Baumann I;
    Ann Hematol; 2005 Jul; 84(7):429-33. PubMed ID: 15838669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group.
    Arnold R; de Witte T; van Biezen A; Hermans J; Jacobsen N; Runde V; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1998 Jun; 21(12):1213-6. PubMed ID: 9674854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How to improve the results of treatment of myelodysplastic syndromes in the studies of Polish pediatric leukemia/lymphoma group].
    Chybicka A; Kołecki P; Pietras W; Wójcik D; Turkiewicz D; Armata J; Eliasińska A; Kowalczyk J; Jackowska T; Klus K; Matysiak M; Krauze A; Stefańska K; Rokicka-Milewska R; Wiśniewska-Slusarz H
    Wiad Lek; 1998; 51 Suppl 4():45-51. PubMed ID: 10731943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
    Giralt S
    Curr Hematol Rep; 2005 May; 4(3):200-7. PubMed ID: 15865872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry.
    del Cañizo MC; Martínez C; Conde E; Vallejo C; Brunet S; Sanz G; Mateos MV;
    Bone Marrow Transplant; 2003 Nov; 32(10):987-92. PubMed ID: 14595386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia.
    Ikushima S; Hibi S; Todo S; Sawada T; Matsumoto Y; Iwami H; Tsunamoto K; Kasubuchi Y; Yabe M; Kato S
    Bone Marrow Transplant; 1995 Oct; 16(4):621-4. PubMed ID: 8528182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome].
    Sato N; Takayama N; Kizaki M; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2003 May; 44(5):318-22. PubMed ID: 12822406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome.
    Tamura K; Kanazawa T; Suzuki M; Koitabashi M; Ogawa C; Morikawa A
    Am J Hematol; 2006 Feb; 81(2):139-41. PubMed ID: 16432864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for myelodysplastic syndrome--who? when? and which?
    Luger S; Sacks N
    Bone Marrow Transplant; 2002 Aug; 30(4):199-206. PubMed ID: 12203135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: the Brazilian experience in the past decade.
    Valera ET; Latorre Mdo R; Mendes WL; Seber A; Lee ML; de Paula MJ; Loggetto SR; Velloso E; Niero-Melo L; Lopes LF;
    Leuk Res; 2004 Sep; 28(9):933-9. PubMed ID: 15234570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Díaz-Heredia C; Badell I; Bureo E; Gómez P; Martínez A; Verdeguer A; Pérez-Hurtado JM; Fernández-Delgado R; González-Vicent M; Maldonado MS
    Pediatr Hematol Oncol; 2009; 26(5):345-55. PubMed ID: 19579081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation (BMT) in a patient with myelodysplastic syndrome (MDS) infected by hepatitis B virus (HBV) precore mutant: favorable outcome with slow tapering of immunosuppressive agents.
    Kikuchi A; Kagimoto S; Kishimoto H; Yamamoto K; Hanada R
    Leukemia; 2002 Nov; 16(11):2333-5. PubMed ID: 12399982
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
    Depil S; Deconinck E; Milpied N; Sutton L; Witz F; Jouet JP; Damaj G; Yakoub-Agha I;
    Bone Marrow Transplant; 2004 Mar; 33(5):531-4. PubMed ID: 14716345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for children with myelodysplastic syndrome.
    Uçkan D; Cetin M; Hiçsönmez G; Tezcan I; Tuncer AM
    Turk J Pediatr; 2000; 42(3):192-7. PubMed ID: 11105616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
    Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
    Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.